**Novartis Launches Tender Offer to Acquire Tourmaline Bio for $48 Per Share** **BASEL, Switzerland** – Global healthcare company Novartis announced Monday it has commenced a cash tender offer to acquire all outstanding shares of Tourmaline Bio, Inc. The offer, made through a Novartis subsidiary, is for $48 per share. It follows a merger agreement between … Continue reading Novartis Launches Tender Offer to Acquire Tourmaline Bio for $48 Per Share